AstraZeneca PLC (AZN)
AZN Price and Sentiment
AZN Latest news
AstraZeneca's therapy could have at least one major advantage.
Moderna has likely peaked. There are much safer growth stocks to buy right now.
AstraZeneca PLC is the best bet in the pharma sector according to analysts at JP Morgan and even after a recent share price recovery there is still lots of value to be had, says the US bank. The pharma's medium-term growth prospects are yet to be fully reflected in the Anglo-Swedish group's valuation, said the bank in a note.
AstraZeneca Plc (NASDAQ: AZN) has paused an active Phase 1 trial of AZD5991, a direct inhibitor of MCL-1, citing a potential safety issue. Two years ago, the FDA hit Amgen Inc (NASDAQ: AMGN) with a clinical hold on its MCL-1 inhibitor AMG 397 following signs of cardiac toxicity.
AstraZeneca Announces Winners and Recognizes Oncology Change Makers in Third Annual Cancer Community Awards2021-10-20 09:00
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca, in partnership with Scientific American Custom Media, today announced the winners of the third annual Cancer Community Awards (or C2 Awards). A part of the AstraZeneca YOUR Cancer program, the C2 Awards celebrate diverse individuals and organizations creating meaningful change in the lives of people with cancer and their loved ones across five unique categories. This year, a new Catalyst for Equity Award category was introduced to recognize those
This gene-therapy specialist may need some help turning things around.
The Nasdaq looks poised to open slightly lower after a strong week.
Two doses of either the vaccine made by Pfizer PFE, -0.43% and BioNTech [s:bntx] or Oxford-AstraZeneca AZN, +0.92% vaccines provided a similar level of protection to prior natural infection when the Delta variant was dominant, the U.K. Office of National Statistics said Monday. Vaccination significantly reduced the risk of people testing positive during both the Alpha-dominant period and the Delta-dominant period, but effectiveness was reduced in the Delta-dominant period compared with the Alpha-dominant period.